Advertisement

Branched Dna (bdna) Technology

  • Mickey Urdea
  • Linda Wuestehube
Part of the Springer Lab Manuals book series (SLM)

Abstract

The branched DNA (bDNA) assay provides a unique and powerful tool for reliable quantification of nucleic acid molecules. Fundamentally different from target amplification methods such as PCR, the bDNA assay directly measures nucleic acid molecules at physiological levels by boosting the reporter signal, rather than replicating target sequences as the means of detection, and hence avoids the errors inherent in the extraction and amplification of target sequences. The bDNA assay employs linear signal amplification using synthetic oligonucleotide probes and bDNA molecules, and can accurately and precisely measure between approximately 500 and 10,000,000 molecules. New advances in bDNA technology include the addition of preamplifier molecules and the incorporation of novel nucleotides, isoC and isoG, into oligonucleotide probe sequences to further enhance signal and reduce noise caused by nonspecific hybridization of bDNA assay components (Kern et al., 1996; Collins et al., 1999). These improvements have extended the quantitative detection limit of the bDNA assay to as low as 50 molecules.

Keywords

Sodium Dodecyl Sulfate Human Immunodeficiency Virus Type Target Probe Nucleic Acid Molecule Specific Nucleotide Sequence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Breen EC, Salazar-Gonzales JF, Shen LP, Kolberg JA, Urdea MS, Martinez-Maza O, Fahey JL (1997) Circulating CD8 T cells show increased interferon-y # mRNA expression in HIV infection. Cell Immunol 178:91–98PubMedCrossRefGoogle Scholar
  2. Chernoff DN, Miner RC, Hoo BS, Shen L-P, Kelso RJ, Jekic-McMullen D, Lalezari JP, Chou S, Drew WL, Kolberg JA (1997) Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched DNA signal amplification assay. J Clin Microbiol 35:2740–2744PubMedGoogle Scholar
  3. Collins ML, Irvine B, Tyner D, Fine E, Zayati C, Chang C A, Horn T, Ahle D, Detmer J, Shen L-P, Kolberg J, Bushnell S, Urdea MS, Ho DD (1997) A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res 25:2979–2984PubMedCrossRefGoogle Scholar
  4. Davis GL, Lau JYN, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, Perrillo RP, Albrecht J (1994) Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 19:1337–1341PubMedCrossRefGoogle Scholar
  5. Detmer J, Lagier R, Flynn J, Zayati C, Kolberg J, Collins M, Urdea M, Sánchez-Pescador R (1996) Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched DNA technology. J Clin Microbiol 34:901–907PubMedGoogle Scholar
  6. Flood J, Drew WL, Miner R, Jekic-McMullen D, Shen L-P, Kolberg J, Garvey J, Follansbee S, Poscher M (1997) Diagnosis of cytomegalovirus (CMV) polyradiculopathy and documentation ofin vivoanti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays. J Infect Dis 176:348–352PubMedCrossRefGoogle Scholar
  7. Hendricks DA, Stowe BS, Hoo BJ, Kolberg J, Irvine BD, Neuwald PD, Urdea MS, Perrillo RP (1995) Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Amer J Clin Pathol 104:537–546Google Scholar
  8. Kern D, Collins M, Fultz T, Detmer J, Hamren S, Peterkin JJ, Sheridan P, Urdea M, White R, Yeghiazarian T, Todd J (1996) An enhanced sensitivity branched: DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 34:3196–3202PubMedGoogle Scholar
  9. Kolberg JA, Ludtke DN, Shen L-P, Cao W, O’Conner D, Urdea MS, Wuestehube LJ, Lewis M (1998) Branched DNA (bDNA) technology for direct quantification of nucleic acids: research and clinical applications. In Ferré F (Ed) Gene quantification. Birkhäuser, BostonGoogle Scholar
  10. Shen L-P, Sheridan P, Cao WW, Dailey PJ, Salazar-Gonzales JF, Breen EC, Fahey JL, Urdea MS, Kolberg JA (1998) Quantification of cytokine mRNA in peripheral blood mononuclear cells using branched DNA (bDNA) technology. J Immunol Methods 215:123–134PubMedCrossRefGoogle Scholar
  11. Terrault NA, Dailey PJ, Ferrell L, Collins ML, Wilber JC, Urdea MS, Bhandari BN, Wright TL (1997) Hepatitis C virus: quantitation and distribution in liver. J Med Virol 51: 217–224PubMedCrossRefGoogle Scholar
  12. Wang J, Shen L P, Najafi H, Kolberg J A, Mastchinsky FM, Urdea M, German M (1997) Regulation of insulin preRNA splicing by glucose. Proc Natl Acad Sci USA 94:4360–4365PubMedCrossRefGoogle Scholar
  13. Yeghiazarian T, Zhao Y, Read SE, Kabat W, Li X, Hamren SJ, Sheridan PJ, Wilber JC, Chernoff DN, Yogev R (1998) Quantification of human immunodeficiency virus type 1 RNA levels in plasma by using small-volume-format branched-DNA assays. J Clin Microbiol 36:2096–2098PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • Mickey Urdea
    • 1
  • Linda Wuestehube
  1. 1.Bayer DiagnosticsEmeryvilleUSA

Personalised recommendations